GlassScriptPhysician profile
Kaye L Elamparo
NPI 1851673610
$4,095.73
in general payments reported to CMS, 2019-2025
20 companies · $2,833 in 2025
The $2,833 reported for 2025 was more than what 97% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $434 · 2022: $424 · 2023: $73.98 · 2024: $330 · 2025: $2,833.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,965 · Food and Beverage: $1,273.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,965.08 |
| Food and Beverage | $1,272.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ctl Medical Corporation | $1,295.73 | 2025 | Raphael Pedicle Screw System |
| Nexxt Spine LLC | $980.62 | 2025 | Nexxt Spine Technology, Nexxt Spine Product Portfolio |
| Medtronic, INC. | $339.57 | 2021-2025 | Linq II |
| Boston Scientific Corporation | $259.75 | 2022-2024 | Wavewriter Alpha Prime 16 |
| Saluda Medical Americas, INC. | $257.82 | 2025 | Evoke |
| Integra Lifesciences Corporation | $231.28 | 2021 | |
| Stryker Corporation | $130.60 | 2024 | Duramatrix, Adherus Autospray Dural Sealant |
| Abbott Laboratories | $126.86 | 2021-2024 | Penta, Proclaim |
| Globus Medical, INC. | $124.70 | 2025 | Modulus, Reline, Harvest |
| Abbvie INC. | $85.61 | 2021-2025 | |
| Daiichi Sankyo INC. | $51.15 | 2023-2024 | Injectafer |
| Innovasis INC | $29.06 | 2025 | |
| Nevro Corp. | $26.39 | 2023 | Senza |
| Monteris Medical Corporation | $26.08 | 2024 | Neuroblate |
| Livanova USA, INC. | $24.90 | 2024 | Vns Therapy Symmetry Model 8103 Generator |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $24.59 | 2024 | Iovera, Exparel |
| Arteriocyte Medical Systems, INC. | $22.97 | 2025 | Magellan |
| Si-Bone, INC. | $20.80 | 2025 | |
| Orthofix Medical, INC. | $19.89 | 2025 | Cove |
| Integrity Implants INC. | $17.36 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kaye Elamparo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.